Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Return on Capital Employed (2022 - 2025)

TriSalus Life Sciences (TLSI) has 4 years of Return on Capital Employed data on record, last reported at 1.1% in Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 123.0% year-over-year to 1.1%; the TTM value through Dec 2025 reached 1.1%, up 123.0%, while the annual FY2025 figure was 1.48%, 109.0% up from the prior year.
  • Return on Capital Employed reached 1.1% in Q4 2025 per TLSI's latest filing, up from 1.12% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.13% in Q4 2022 and bottomed at 8.18% in Q1 2024.
  • Average Return on Capital Employed over 4 years is 2.66%, with a median of 2.19% recorded in 2025.
  • Peak YoY movement for Return on Capital Employed: plummeted -682bps in 2024, then skyrocketed 599bps in 2025.
  • A 4-year view of Return on Capital Employed shows it stood at 0.13% in 2022, then plummeted by -2900bps to 3.79% in 2023, then soared by 38bps to 2.33% in 2024, then surged by 53bps to 1.1% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 1.1% in Q4 2025, 1.12% in Q3 2025, and 1.21% in Q2 2025.